400 related articles for article (PubMed ID: 28574171)
1. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.
Kagey MH; He X
Br J Pharmacol; 2017 Dec; 174(24):4637-4650. PubMed ID: 28574171
[TBL] [Abstract][Full Text] [Related]
2. The Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.
Kikuchi A; Fumoto K; Kimura H
Br J Pharmacol; 2017 Dec; 174(24):4651-4665. PubMed ID: 28514532
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors.
Zimmerli D; Hausmann G; Cantù C; Basler K
Br J Pharmacol; 2017 Dec; 174(24):4600-4610. PubMed ID: 28521071
[TBL] [Abstract][Full Text] [Related]
4. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.
Driehuis E; Clevers H
Br J Pharmacol; 2017 Dec; 174(24):4547-4563. PubMed ID: 28244067
[TBL] [Abstract][Full Text] [Related]
5. WNT signalling: mechanisms and therapeutic opportunities.
Schulte G; Bryja V
Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
[TBL] [Abstract][Full Text] [Related]
6. Molecular regulation and pharmacological targeting of the β-catenin destruction complex.
van Kappel EC; Maurice MM
Br J Pharmacol; 2017 Dec; 174(24):4575-4588. PubMed ID: 28634996
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
Mariotti L; Pollock K; Guettler S
Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.
Lyou Y; Habowski AN; Chen GT; Waterman ML
Br J Pharmacol; 2017 Dec; 174(24):4589-4599. PubMed ID: 28752891
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Schmidt J; Mackinnon A; Venu N; Shaker R
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G557-74. PubMed ID: 24481601
[TBL] [Abstract][Full Text] [Related]
10. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.
Flanagan DJ; Vincan E; Phesse TJ
Br J Pharmacol; 2017 Dec; 174(24):4666-4683. PubMed ID: 28568899
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-1: A Promising Target for Cancer Immunotherapy.
Chu HY; Chen Z; Wang L; Zhang ZK; Tan X; Liu S; Zhang BT; Lu A; Yu Y; Zhang G
Front Immunol; 2021; 12():658097. PubMed ID: 34093545
[TBL] [Abstract][Full Text] [Related]
12. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
[TBL] [Abstract][Full Text] [Related]
13. DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity.
Menezes ME; Mitra A; Shevde LA; Samant RS
Biochem J; 2012 Jun; 444(3):573-80. PubMed ID: 22455953
[TBL] [Abstract][Full Text] [Related]
14. Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.
Janovská P; Bryja V
Br J Pharmacol; 2017 Dec; 174(24):4701-4715. PubMed ID: 28703283
[TBL] [Abstract][Full Text] [Related]
15. Assembly and architecture of the Wnt/β-catenin signalosome at the membrane.
DeBruine ZJ; Xu HE; Melcher K
Br J Pharmacol; 2017 Dec; 174(24):4564-4574. PubMed ID: 28941231
[TBL] [Abstract][Full Text] [Related]
16. 'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.
Ong MS; Cai W; Yuan Y; Leong HC; Tan TZ; Mohammad A; You ML; Arfuso F; Goh BC; Warrier S; Sethi G; Tolwinski NS; Lobie PE; Yap CT; Hooi SC; Huang RY; Kumar AP
Br J Pharmacol; 2017 Dec; 174(24):4684-4700. PubMed ID: 28736855
[TBL] [Abstract][Full Text] [Related]
17. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf signaling, beyond Wnt-mediated biology.
Kikuchi A; Matsumoto S; Sada R
Semin Cell Dev Biol; 2022 May; 125():55-65. PubMed ID: 34801396
[TBL] [Abstract][Full Text] [Related]
19. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway.
Liang L; Tu Y; Lu J; Wang P; Guo Z; Wang Q; Guo K; Lan R; Li H; Liu P
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028181
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.
Menet R; Bourassa P; Calon F; ElAli A
Neurochem Int; 2020 Dec; 141():104881. PubMed ID: 33068684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
